Cargando…
Prediction of Conversion from Mild Cognitive Impairment to Alzheimer’s Disease Using Amyloid PET and Brain MR Imaging Data: A 48-Month Follow-Up Analysis of the Alzheimer’s Disease Neuroimaging Initiative Cohort
We developed a novel quantification method named “shape feature” by combining the features of amyloid positron emission tomography (PET) and brain magnetic resonance imaging (MRI) and evaluated its significance in predicting the conversion from mild cognitive impairment (MCI) to Alzheimer’s disease...
Autores principales: | Kim, Do-Hoon, Oh, Minyoung, Kim, Jae Seung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650660/ https://www.ncbi.nlm.nih.gov/pubmed/37958271 http://dx.doi.org/10.3390/diagnostics13213375 |
Ejemplares similares
-
Neuroimage Biomarker Identification of the Conversion of Mild Cognitive Impairment to Alzheimer’s Disease
por: Kung, Te-Han, et al.
Publicado: (2021) -
[(18)F]THK-5351 PET Patterns in Patients With Alzheimer’s Disease and Negative Amyloid PET Findings
por: Oh, Minyoung, et al.
Publicado: (2022) -
Topographical Heterogeneity of Alzheimer’s Disease Based on MR Imaging, Tau PET, and Amyloid PET
por: Jeon, Seun, et al.
Publicado: (2019) -
A review of β-amyloid neuroimaging in Alzheimer's disease
por: Adlard, Paul A., et al.
Publicado: (2014) -
Structural MRI and Amyloid PET Imaging for Prediction of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment: A Meta-Analysis
por: Seo, Eun Hyun, et al.
Publicado: (2017)